Main Question or Discussion Point
note: Phase I is just safety testing, not efficacy. Still exciting, though!
http://communications.uwo.ca/media/...i_clinical_trial_of_sumagen_aids_vaccine.htmlSumagen Canada Inc and Western University announced today that the Phase I Clinical Trial (SAV CT 01) of the first and only preventative HIV vaccine based on a genetically modified killed whole virus (SAV001-H) has been successfully completed with no adverse effects in all patients. Antibody production was also boosted after vaccination.